Sign In
Buy BAX
$18.54
-0.140 (-0.749%)
At Close: Jun 03, 2026
Baxter restarts IV solutions manufacturing line
11:43am, Thursday, 31'st Oct 2024
Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related fl
DUBLIN--(BUSINESS WIRE)--Oneview Healthcare, a leading provider of patient experience solutions is pleased to announce the extension of its strategic relationship with Baxter International Inc. for an
Baxter expects to restart IV solutions manufacturing line within next week
11:43am, Thursday, 24'th Oct 2024
Medical device maker Baxter said on Thursday it expects to restart the highest-throughput IV solutions manufacturing line at a hurricane-hit plant in North Carolina within the next week.
Baxter to Present at UBS Global Healthcare Conference
04:15pm, Wednesday, 23'rd Oct 2024
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxte
Baxter aims to restore new dialysis patient access to pre-hurricane levels by year-end
01:41pm, Monday, 21'st Oct 2024
Baxter International on Monday said that it aims to restore the number of new patients able to begin using its peritoneal dialysis solutions to pre-Hurricane Helene levels by the end of the year.
BAX or LMAT: Which Is the Better Value Stock Right Now?
12:45pm, Friday, 18'th Oct 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Baxter International (BAX) or LeMaitre Vascular (LMAT). But which of these two companies is the best option
Should Value Investors Buy Baxter International (BAX) Stock?
10:45am, Friday, 18'th Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Baxter to import 18,000 tons of IV products to US by year-end
01:15pm, Thursday, 17'th Oct 2024
Baxter International said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the end of the year to mitigate a shortage caused by
Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors
04:15pm, Wednesday, 16'th Oct 2024
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8,
Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore
09:14am, Monday, 14'th Oct 2024
The Federal Reserve's rate cut historically boosts healthcare stocks, and Baxter International's recent downturn presents a buying opportunity due to overblown market reactions. Baxter's acquisition o
Reasons to Add Baxter International Stock to Your Portfolio Now
08:11am, Friday, 04'th Oct 2024
BAX's robust growth across all regions, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Here's Why Baxter International (BAX) is a Strong Value Stock
10:47am, Thursday, 03'rd Oct 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BAX vs. LMAT: Which Stock Is the Better Value Option?
12:46pm, Wednesday, 02'nd Oct 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Baxter International (BAX) or LeMaitre Vascular (LMAT). But which of these two stocks presents investors wit
Are Investors Undervaluing Baxter International (BAX) Right Now?
10:46am, Wednesday, 02'nd Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Does Baxter Stock Offer Any Room For Growth?
08:00am, Tuesday, 01'st Oct 2024
Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickins
